News

nRichDX Launches Revolution Sample Prep Semi-Automated Workflow

New workflow automates key steps in the extraction of cfDNA and ctDNA from blood and urine samples - an essential step in the development of liquid-based assays.   IRVINE, Calif., Jan. 27, 2021– nRichDX® Inc. announces the launch of its Semi-Automated Revolution™ Sample Prep Workflow powered by Eppendorf for extraction of cfDNA and ctDNA from a wide range of input sample volumes from 3 mL-20 mL with market-leading yields and recovery rates of 70%-90%....

nRichDx Targets Liquid Biopsy Space With Magnetic Sample Prep Platform

Article Published by GenomeWeb (New York, NY. October 23, 2019) – Launching its semi-automated magnetic-based sample prep platform...

nRichDX Introduces High-Yield Sample Prep for Liquid Biopsies

(Irvine, CA. September 20, 2019) – nRichDX Inc. announces the launch of its Revolution™ System, a high-yield sample...

Corporate Advisory Board Formation

(Irvine, CA.  August 1, 2019) – nRichDX Inc. is pleased to announce the formation of a Corporate Advisory...

Massachussetts General Hospital Cancer Center to Participate in Evaluation of nRichDX Revolution System

  (Irvine, CA.  April 24, 2019) – nRichDX Inc. is pleased to confirm that, under the direction of Ryan...

Dartmouth-Hitchcock Medical Center To Participate in Evaluation of nRichDX Revolution System

(Irvine, CA.  April 19, 2019) – nRichDX Inc. is pleased to confirm that, under the direction of Gregory...

Scientific Advisory Board Formation

(Irvine, CA.  December 1, 2019) – nRichDX Inc. is pleased to announce the formation of our Scientific Advisory...

Events

nRichDx Announces Unveiling of Revolution System™ at 2019 AMP Annual Meeting

Increase liquid biopsy-based test sensitivity by delivering exponentially more target input for molecular assays  ...